Penumbra Inc. (PEN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Penumbra Inc. (PEN:NYSE), powered by AI.

Current Price
$318.46
P/E Ratio
69.8
Market Cap
12.4B
Sector
Healthcare
What is the Penumbra Inc. stock price forecast?

Penumbra Inc. is currently trading at $318.46. View real-time AI analysis on Alpha Lenz.

What is Penumbra Inc. insider trading activity?

View the latest insider trading data for Penumbra Inc. on Alpha Lenz.

What is Penumbra Inc.'s P/E ratio?

Penumbra Inc.'s P/E ratio is 69.8.

Penumbra Inc.

NYSE · PEN
$318.46+0.25(+0.08%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Penumbra Inc.'s future dividend policy...
Alpha Chat Insight

Penumbra Inc. trades at a P/E of 69.8 (premium valuation) with solid ROE of 13.8%. 3Y revenue CAGR of 18.3% highlights clear growth momentum.

Ask for details

Company Overview

Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the company operates within the specialized field of interventional therapies, particularly in neuro and vascular medical devices. Penumbra’s products are crucial for addressing critical conditions such as stroke and peripheral artery diseases. By pioneering minimally invasive solutions, the company significantly contributes to enhancing patient outcomes and reshaping intervention methods in the medical field. Founded in 2004 and headquartered in Alameda, California, Penumbra plays a vital role in the medical device industry with its commitment to advancing healthcare technologies. Its solutions are not only pivotal in specialized medical procedures but also support the healthcare ecosystem's broader objective of improving care and saving lives, making it a key entity amongst healthcare providers and hospitals worldwide.

CEOMr. Adam Elsesser J.D.
SectorHealthcare
IndustryMedical Devices
Employees4,500

Company Statistics

FY 2025

Profile

$12.39BMarket Cap
$1.40BRevenue
0.00Shares Out
4,500Employees

Margins

67.14%Gross
15.95%EBITDA
13.48%Operating
14.61%Pre-Tax
12.66%Net

Valuation

69.75P/E
8.68P/B
8.83EV/Sales
55.50EV/EBITDA
70.85P/FCF

Growth (CAGR)

18.33%Rev 3Yr
20.16%Rev 5Yr
214.53%Op Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

10.58%ROA
13.78%ROE
12.29%ROIC

Financial Health

$186.90MCash & Cash Equivalents
$212.02MNet Debt
27.94%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Penumbra Inc. (ticker: PEN) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 4,500 employees. Market cap is $12.4B.

The current price is $318.46 with a P/E ratio of 69.75x and P/B of 8.68x.

ROE is 13.78% and operating margin is 13.48%. Annual revenue is $1.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Penumbra Inc. (PEN) Stock Forecast 2026 $318.46 — Price, Financials & Analyst Targets | Alpha Lenz